AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32093664 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse care coordination program
Number of subjects: 3007
Study 34914868 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir (800 mg twice daily for 5 days)
Number of subjects: 1433
Study 34914868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1433
Study 34914868 — intervention group
Group type: EXPERIMENTAL
Intervention: Molnupiravir
Number of subjects: 1433
Study 33295137 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricalcium phosphate with or without hyaluronic acid (HA)
Number of subjects: 24
Study 33295137 — intervention group
Group type: COMPARATOR
Intervention: Anorganic bovine bone mineral
Number of subjects: 24
Study 32417533 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-activated CBFv from 69 healthy participants for five cognitive tasks (attention, verbal fluency, language, visuospatial, memory)
Number of subjects: 135
Study 35962311 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice water injection (250 ml) toward the duodenal papilla at the end of ERCP
Number of subjects: 440
Study 35962311 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ice water injection)
Number of subjects: 440
Study 33258566 — intervention group
Group type: EXPERIMENTAL
Intervention: Oversized stent (oversized by 10% according to mean lumen diameter)
Number of subjects: 122
Study 33258566 — intervention group
Group type: COMPARATOR
Intervention: Non-oversized stent (control group)
Number of subjects: 122
Study 33258566 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (oversized and non-oversized)
Number of subjects: 122
Study 33136077 — intervention group
Group type: EXPERIMENTAL
Intervention: Real contra‐lesion low frequency repetitive transcranial magnetic stimulation (LF‐rTMS)
Number of subjects: 40
Study 33136077 — intervention group
Group type: COMPARATOR
Intervention: Sham contra‐lesion low frequency repetitive transcranial magnetic stimulation (LF‐rTMS)
Number of subjects: 40
Study 33136077 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy program for the upper limb
Number of subjects: 40
Study 35364115 — intervention group
Group type: EXPERIMENTAL
Intervention: Best-Worst Scaling (BWS) survey
Number of subjects: 300
Study 32914852 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-based behavioral obesity treatment (FBT) for 4 months
Number of subjects: 172
Study 32914852 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight maintenance interventions for 8 months
Number of subjects: 172
Study 32914852 — intervention group
Group type: EXPERIMENTAL
Intervention: Latent profiles of general psychopathology (GP) and eating disorder psychopathology (EDP)
Number of subjects: 172
Study 36154912 — intervention group
Group type: EXPERIMENTAL
Intervention: Erector spinae plane block (ESPB)
Number of subjects: 60
Study 36154912 — intervention group
Group type: COMPARATOR
Intervention: Subcostal transversus abdominis plane block (TAPB)
Number of subjects: 60
Study 34391248 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates exercise (8-week group-supervised, mat-based program)
Number of subjects: 39
Study 34391248 — intervention group
Group type: COMPARATOR
Intervention: Usual pharmacologic and rehabilitation standard of care (control group)
Number of subjects: 39
Study 32711878 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterologous bone graft and nanohydroxyapatite (NHA)
Number of subjects: 26
Study 32711878 — intervention group
Group type: COMPARATOR
Intervention: Pure graft (heterologous bone graft only)
Number of subjects: 26
Study 32711878 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Group A and Group B)
Number of subjects: 26
Study 35609671 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (up to 20 mg)
Number of subjects: 120
Study 35609671 — intervention group
Group type: COMPARATOR
Intervention: Exercise (3 times/wk)
Number of subjects: 120
Study 35609671 — intervention group
Group type: COMPARATOR
Intervention: Placebo pill
Number of subjects: 120
Study 33047944 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical proprioception exercises
Number of subjects: 42
Study 33047944 — intervention group
Group type: COMPARATOR
Intervention: Cervical mobility exercises
Number of subjects: 42
Study 32686487 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment (testing, in-person feedback, and two calls from a care-coordinator)
Number of subjects: 49
Study 32686487 — intervention group
Group type: COMPARATOR
Intervention: Standard-care treatment (neuropsychological testing and phone feedback)
Number of subjects: 49
Study 32686487 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (experimental and standard-care)
Number of subjects: 49
Study 32686487 — intervention group
Group type: COMPARATOR
Intervention: Experimental treatment and Standard-care treatment
Number of subjects: 49
Study 32686487 — intervention group
Group type: COMPARATOR
Intervention: Standard-care treatment
Number of subjects: 49
Study 32686487 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental treatment
Number of subjects: 49
Study 36498425 — intervention group
Group type: EXPERIMENTAL
Intervention: Practicing acts of kindness
Number of subjects: 122
Study 36498425 — intervention group
Group type: COMPARATOR
Intervention: Neutral intervention (practicing acts related to studying)
Number of subjects: 122
Study 35847566 — intervention group
Group type: EXPERIMENTAL
Intervention: B-OPAT (Buprenorphine plus OPAT)
Number of subjects: 90
Study 35847566 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 90
Study 33255807 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (150,000 IU)
Number of subjects: 27
Study 33255807 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 33255807 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Vitamin D3 and Placebo)
Number of subjects: 27
Study 33769666 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein/low-carbohydrate diet (HPD)
Number of subjects: 15
Study 33769666 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean/low glycaemic index diet (MED)
Number of subjects: 15
Study 33769666 — intervention group
Group type: COMPARATOR
Intervention: Reference diet (REF)
Number of subjects: 15
Study 32975159 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First intervention (community-based scattered-site housing and support services)
Number of subjects: 575
Study 32975159 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 575
Study 35963048 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 0
Study 35963048 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 0
Study 34164929 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent elevated depressive symptom trajectory
Number of subjects: 179
Study 34164929 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated depressive symptoms
Number of subjects: 179
Study 34657367 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted radical cystectomy with intracorporeal urinary diversion (iRARC)
Number of subjects: 50
Study 34657367 — intervention group
Group type: COMPARATOR
Intervention: Open radical cystectomy (ORC)
Number of subjects: 50
Study 34657367 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 33593341 — intervention group
Group type: COMPARATOR
Intervention: Passive physical treatment
Number of subjects: 9328
Study 33593341 — intervention group
Group type: COMPARATOR
Intervention: Psychological treatment
Number of subjects: 9328
Study 33593341 — intervention group
Group type: COMPARATOR
Intervention: Active physical treatment
Number of subjects: 9328
Study 33608106 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional cigarette smoke (Marlboro Medium; Philip Morris)
Number of subjects: 90
Study 33608106 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated tobacco product smoke (IQOS 2.4 plus holder, Marlboro Heets Silver; Philip Morris)
Number of subjects: 90
Study 33608106 — intervention group
Group type: COMPARATOR
Intervention: Control group (exposed to air)
Number of subjects: 90
Study 33109246 — intervention group
Group type: EXPERIMENTAL
Intervention: favipiravir with interferon beta‐1a
Number of subjects: 60
Study 33109246 — intervention group
Group type: COMPARATOR
Intervention: lopinavir/ritonavir with interferon beta‐1a
Number of subjects: 60
Study 33706065 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ozonated oil, applied twice a day for 60 days
Number of subjects: 80
Study 33706065 — intervention group
Group type: COMPARATOR
Intervention: Placebo (non-ozonated oil), applied twice a day for 60 days
Number of subjects: 80
Study 32892758 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery rescripting (ImRs)
Number of subjects: 155
Study 32892758 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye movement desensitisation and reprocessing (EMDR)
Number of subjects: 155
Study 32892758 — intervention group
Group type: COMPARATOR
Intervention: Imagery rescripting (ImRs) and Eye movement desensitisation and reprocessing (EMDR)
Number of subjects: 155
Study 32247284 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian nonparametric approach
Number of subjects: 0
Study 32247284 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation studies
Number of subjects: 0
Study 32247284 — intervention group
Group type: EXPERIMENTAL
Intervention: Data from a brain cancer trial
Number of subjects: 0
Study 34099023 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture intervention (30 min, 2–3 times/week for 12 weeks)
Number of subjects: 60
Study 34099023 — intervention group
Group type: COMPARATOR
Intervention: Sham control acupuncture intervention (30 min, 2–3 times/week for 12 weeks)
Number of subjects: 60
Study 34099023 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture intervention
Number of subjects: 60
Study 34099023 — intervention group
Group type: COMPARATOR
Intervention: Sham control acupuncture intervention
Number of subjects: 60
Study 32145293 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based continuous training (CTG; n=21)
Number of subjects: 41
Study 32145293 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based interval training (ITG; n=20)
Number of subjects: 41
Study 33952378 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative care interventions addressing quality delivery
Number of subjects: 0
Study 33952378 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaboration among health institutions for palliative care
Number of subjects: 0
Study 33952378 — intervention group
Group type: EXPERIMENTAL
Intervention: Policies and programs for palliative care
Number of subjects: 0
Study 34260969 — intervention group
Group type: EXPERIMENTAL
Intervention: CRTpowerdist package
Number of subjects: 20
Study 34260969 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulations and analytic formulae
Number of subjects: 20
Study 35405482 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity intermittent exercise (HIIE) session (10 x 1-min sprints with 1 min of rest) at 90% of their maximum aerobic velocity (MAV)
Number of subjects: 14
Study 33770365 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab in combination with bortezomib, melphalan, and prednisone (D-VMP)
Number of subjects: 0
Study 33770365 — intervention group
Group type: COMPARATOR
Intervention: VMP (bortezomib, melphalan, and prednisone)
Number of subjects: 0
Study 32035692 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard chemoradiation combined with recombinant human endostatin injection (Endostar)
Number of subjects: 114
Study 32035692 — intervention group
Group type: COMPARATOR
Intervention: Standard chemoradiation
Number of subjects: 114
Study 33278235 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyedrops (phenylephrine, tropicamide, fluorescein‐proparacaine)
Number of subjects: 62
Study 33278235 — intervention group
Group type: EXPERIMENTAL
Intervention: Goldmann applanation tonometry (GAT)
Number of subjects: 62
Study 33278235 — intervention group
Group type: COMPARATOR
Intervention: Control (contralateral eye measurements)
Number of subjects: 62
Study 32425051 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 300
Study 32425051 — intervention group
Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 300
Study 35109763 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg vitamin B6 daily
Number of subjects: 8
Study 35109763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 34044341 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended case-centred learning
Number of subjects: 0
Study 34044341 — intervention group
Group type: COMPARATOR
Intervention: Offline case-centred learning
Number of subjects: 0
Study 33211728 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC® Video-Stylet (VS)
Number of subjects: 21
Study 33211728 — intervention group
Group type: COMPARATOR
Intervention: C-MAC Macintosh video laryngoscope (VL)
Number of subjects: 21
Study 35859471 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 27
Study 35859471 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 27
Study 32791945 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted arm training with WAM (RAT-WAM)
Number of subjects: 40
Study 32791945 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted arm training with Proficio (RAT-P)
Number of subjects: 40
Study 36130313 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Group
Number of subjects: 403
Study 36130313 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Group
Number of subjects: 403
Study 36130313 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 403
Study 37589610 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-activation tool for intensification of medications for chronic heart failure
Number of subjects: 292
Study 33073594 — intervention group
Group type: EXPERIMENTAL
Intervention: Graphic risk messages
Number of subjects: 601
Study 33073594 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk education messages
Number of subjects: 601
Study 33073594 — intervention group
Group type: COMPARATOR
Intervention: Instagram ads alone
Number of subjects: 601
Study 32739670 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional care intervention including risk assessment for early readmission, health education from admission to predischarge, individualized discharge planning, and weekly telephone follow-up for one month and WeChat follow-up postdischarge.
Number of subjects: 220
Study 32739670 — intervention group
Group type: EXPERIMENTAL
Intervention: Transitional care intervention
Number of subjects: 220
Study 32739670 — intervention group
Group type: COMPARATOR
Intervention: Routine care of comparable length and follow-up contact
Number of subjects: 220
Study 35177070 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention stores with modified availability, accessibility, and promotion of fruits and vegetables, including a customer-directed marketing campaign for 6 months.
Number of subjects: 369
Study 35177070 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention stores
Number of subjects: 369
Study 35177070 — intervention group
Group type: COMPARATOR
Intervention: Control stores
Number of subjects: 369
Study 34029936 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual diaphragmatic stretching technique (MDST) alongside standard physiotherapy (SDPT)
Number of subjects: 53
Study 34029936 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy (SDPT)
Number of subjects: 53
Study 32994020 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol/ethanol 10 mg/mL
Number of subjects: 64
Study 32994020 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 mg/mL resveratrol/ethanol)
Number of subjects: 64
Study 35691791 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal gonadorelin treatment
Number of subjects: 36
Study 35691791 — intervention group
Group type: COMPARATOR
Intervention: Control (no gonadorelin treatment)
Number of subjects: 36
Study 33482396 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted mailings
Number of subjects: 874
Study 33482396 — intervention group
Group type: COMPARATOR
Intervention: Brochure/flyer
Number of subjects: 874
Study 33482396 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment methods
Number of subjects: 874
Study 32622768 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel penile splint (Early Traction Therapy - ETT) applied post-surgery
Number of subjects: 46
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Women's own experiences of witnessing their mother being physically abused
Number of subjects: 744
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Poverty during childhood
Number of subjects: 744
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Current food insecurity
Number of subjects: 744
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Husband using corporal punishment on their child
Number of subjects: 744
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Current IPV experience
Number of subjects: 744
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Other violence in the home
Number of subjects: 744
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood trauma and poverty pathways mediated by poor mental health
Number of subjects: 744
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood trauma and poverty pathways mediated by wider use of violence in the home
Number of subjects: 744
Study 34360216 — intervention group
Group type: EXPERIMENTAL
Intervention: Childhood trauma and poverty pathways mediated by food insecurity and gender inequitable attitudes
Number of subjects: 744
Study 33250386 — intervention group
Group type: EXPERIMENTAL
Intervention: JUUL System 5.0 % nicotine concentration
Number of subjects: 146
Study 33250386 — intervention group
Group type: EXPERIMENTAL
Intervention: JUUL System 3.0 % nicotine concentration
Number of subjects: 146
Study 33250386 — intervention group
Group type: COMPARATOR
Intervention: Usual brand (UB) cigarette
Number of subjects: 146
Study 33250386 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg mint nicotine gum
Number of subjects: 146
Study 33250386 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparator ENDS (VUSE Alto 5.0 % nicotine)
Number of subjects: 146
Study 33350480 — intervention group
Group type: EXPERIMENTAL
Intervention: High probability of automation jobs
Number of subjects: 14948
Study 33350480 — intervention group
Group type: EXPERIMENTAL
Intervention: Low probability of automation jobs
Number of subjects: 14948
Study 33350480 — intervention group
Group type: EXPERIMENTAL
Intervention: Automation probability
Number of subjects: 14948
Study 34507245 — intervention group
Group type: EXPERIMENTAL
Intervention: Images of blue spaces
Number of subjects: 168
Study 34507245 — intervention group
Group type: EXPERIMENTAL
Intervention: Images of green spaces
Number of subjects: 168
Study 34507245 — intervention group
Group type: COMPARATOR
Intervention: Built environments (control group)
Number of subjects: 168
Study 34003364 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD)
Number of subjects: 21
Study 34003364 — intervention group
Group type: COMPARATOR
Intervention: Non-ketogenic diet (NKD)
Number of subjects: 21
Study 34003364 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (KD and NKD)
Number of subjects: 21
Study 35670063 — intervention group
Group type: EXPERIMENTAL
Intervention: nrTMS targeted to S2
Number of subjects: 21
Study 35670063 — intervention group
Group type: EXPERIMENTAL
Intervention: nrTMS targeted to M1
Number of subjects: 21
Study 35670063 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 21
Study 35670063 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold pressor test
Number of subjects: 21
Study 34363386 — intervention group
Group type: EXPERIMENTAL
Intervention: Hestia rule
Number of subjects: 1975
Study 34363386 — intervention group
Group type: COMPARATOR
Intervention: sPESI
Number of subjects: 1975
Study 32150519 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness app usage
Number of subjects: 23
Study 32150519 — intervention group
Group type: COMPARATOR
Intervention: Control (no app usage)
Number of subjects: 23
Study 34112279 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteer befriending intervention (met fortnightly for 6 months)
Number of subjects: 65
Study 34112279 — intervention group
Group type: EXPERIMENTAL
Intervention: Volunteer befriending intervention
Number of subjects: 65
Study 34112279 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (control)
Number of subjects: 65
Study 32732012 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermic intraperitoneal chemotherapy (HIPEC)
Number of subjects: 0
Study 33805484 — intervention group
Group type: EXPERIMENTAL
Intervention: Multispecies probiotic
Number of subjects: 31
Study 33805484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 35417188 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis (EVC001) administered daily for 28 days
Number of subjects: 0
Study 35417188 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis (EVC001)
Number of subjects: 0
Study 35417188 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study 33196773 — intervention group
Group type: EXPERIMENTAL
Intervention: Withholding standard intravenous empirical antibiotics for 48 hours after birth
Number of subjects: 0
Study 33196773 — intervention group
Group type: COMPARATOR
Intervention: Standard intravenous empirical antibiotics for 48 hours after birth
Number of subjects: 0
Study 36184545 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX pretreatment (D1 group)
Number of subjects: 120
Study 36184545 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX posttreatment (D2 group)
Number of subjects: 120
Study 36184545 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX whole‐course pumping (D3 group)
Number of subjects: 120
Study 36184545 — intervention group
Group type: COMPARATOR
Intervention: Control (C group)
Number of subjects: 120
Study 35079088 — intervention group
Group type: EXPERIMENTAL
Intervention: 3CLpro inhibitor PF-07321332
Number of subjects: 0
Study 35079088 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 strains with reduced 3CLpro enzymatic activity
Number of subjects: 0
Study 35079088 — intervention group
Group type: EXPERIMENTAL
Intervention: 3CLpro with Ser108 mutation
Number of subjects: 0